Home > Products > Active Pharmaceutical Ingredient (API)

China Active Pharmaceutical Ingredient (API) Manufacturer, Supplier, Factory

View as  
 
540737-29-9

540737-29-9

540737-29-9 is for rheumatoid arthritis drug, psoriatic arthritis drug, ankylosing spondylitis drug, polyarticular course juvenile idiopathic arthritis drug, ulcerative colitis drug.

Read MoreSend Inquiry
Tofacitinib Citrate API

Tofacitinib Citrate API

Tofacitinib Citrate API is for rheumatoid arthritis drug, psoriatic arthritis drug, ankylosing spondylitis drug, polyarticular course juvenile idiopathic arthritis drug, ulcerative colitis drug.

Read MoreSend Inquiry
6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione

6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione

6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione is for essential hypertension drug.

Read MoreSend Inquiry
6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione Hydrochloride

6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione Hydrochloride

6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione Hydrochloride is for essential hypertension drug.

Read MoreSend Inquiry
CAS NO.64887-14-5

CAS NO.64887-14-5

CAS NO.64887-14-5 is for essential hypertension drug.

Read MoreSend Inquiry
CAS 64887-14-5

CAS 64887-14-5

CAS 64887-14-5 is for essential hypertension drug.

Read MoreSend Inquiry
<...89101112...14>
You can rest assured to buy Active Pharmaceutical Ingredient (API) made in China from our factory. Run'an Pharmaceutical is a professional China Active Pharmaceutical Ingredient (API) manufacturer and supplier, we can provide high quality products. Welcome to buy products from our factory.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept